Jen Brogan is a journalist and editorial assistant for PharmaTimes Media Ltd, writing for publications such as PharmaTimes and PMLiVE. With a focus on healthcare and pharmaceuticals, Jen covers a wide range of topics including medical research, drug development, and healthcare policy. Her articles provide valuable insights into the latest advancements in the field and their impact on patient care.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
International
Jen Brogan's coverage primarily focuses on healthcare and pharmaceuticals, with a strong emphasis on scientific research and data-driven articles. Her work suggests receptiveness to pitches related to new medical advancements, clinical trials, significant findings in cancer research, COVID-19 treatments or studies, antibiotic resistance developments, and other breakthroughs in the healthcare sector.
Given her frequent use of press releases and citations of data along with government announcements in her articles, she may be particularly interested in receiving pitches that offer exclusive access to newsworthy data or insights from experts involved in groundbreaking medical research or clinical trials.
As Jen does not specify a geographic focus, it is likely that she covers global health-related topics without specific regional limitations. Therefore, relevant information from any part of the world could be suitable for her coverage.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Jen Brogan
The progressive neurodegenerative disease is the most common form of dementia
By: Jen Brogan
The collaboration will support solutions to address the health impacts of climate change, infectious diseases and AMR
By: Jen Brogan
Anticancer drugs will be responsible for 90% of nearly 612,000 predicted US cancer deaths in 2024
By: Jen Brogan
The subtype accounts for 20% of all T-cell leukaemias, a rare form of blood cancer which produces too many abnormal T-cells
By: Jen Brogan
The treatment reduced RSV hospitalisations by 82% in infants under six months during the 2023 to 2024 RSV season
By: Jen Brogan
The vaccine provided protection against coronaviruses that have not yet emerged
By: Jen Brogan
For the second month in a row, the NHS has met the 28-day faster diagnosis target for cancer
By: Jen Brogan
The sandbox will help to inform future AI Airlock projects and influence future AlaMD guidance
By: Jen Brogan
The autoimmune skin condition currently affects more than six million people in the US
By: Jen Brogan
Currently the most common cancer in the UK, breast cancer affects over 55,000 people annually
(833) 317-6278 
